Liang Duan

机构：Dalian Medical University, Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University · ORCID：0000-0002-3882-7527

发表论文 117 篇 · 总被引 2445 次 · h-index 28

代表论文

• Fusobacterium nucleatum-triggered neutrophil extracellular traps facilitate colorectal carcinoma progression (2023 · Journal of Experimental & Clinical Cancer Research · 被引 83)
• Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study (2023 · Nature Communications · 被引 46)
• Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II–III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study (2024 · Signal Transduction and Targeted Therapy · 被引 35)
• Neutrophil extracellular traps facilitate liver inflammation/fibrosis progression by entering macrophages and triggering AIM2 inflammasome-dependent pyroptosis (2024 · Cell Communication and Signaling · 被引 28)
• Artificial intelligence driven 3D reconstruction for enhanced lung surgery planning (2025 · Nature Communications · 被引 20)
• Neoadjuvant Aumolertinib for unresectable stage III EGFR-mutant non-small cell lung cancer: a single-arm phase II trial (2025 · Nature Communications · 被引 15)